{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:09:42Z","timestamp":1774026582888,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"1","funder":[{"name":"Danish Heart Foundation - Hjerteforeningen"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2019,4,26]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Heart failure with preserved ejection fraction (HFpEF) involves half of hospitalised patients with heart failure (HF), but estimates vary due to unclear diagnostic criteria. We performed a prospective observational study of hospitalised patients admitted with dyspnoea. The aim was to apply contemporary guidelines to diagnose HF due to valvular disease (HFvhd), HF due to reduced ejection fraction (HFrEF), HF due to midrange EF (HFmrEF) and HFpEF in relation to presumed cardiac or non-cardiac dyspnoea.<\/jats:p>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included consecutive hospitalised patients with presumed HF or dyspnoea and excluded patients with acute coronary syndrome, estimated glomerular filtration rate &lt;30 mL\/min\/1.73\u2009m\u00b2 or low NT-proBNP (&lt;296 ng\/L). Higher age-adjusted NT-proBNP values excluded patients with presumptive non-cardiac dyspnoea. Contemporary criteria for HFpEF and diastolic dysfunction were assessed, and we adjudicated whether acute decompensated HF (ADHF) had been the primary diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 707 eligible patients, we included 370 patients of whom 75 had non-cardiac dyspnoea. Of these, 10% (38\/370) had no cardiac dysfunction. Cardiac dysfunction consisted of 18.4%, HFvhd, 30.1% HFrEF, 10.2% HFmrEF and 41.3% HFpEF. HFpEF was twice as common in presumptive non-cardiac dyspnoea versus cardiac dyspnoea (71% vs 34%, p&lt;0.0001). However, adjudicated ADHF was the primary diagnosis in 80% of HFrEF, 62% of HFmrEF and just 28% of HFpEF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>HF according to contemporary criteria applied to 90% of patients admitted with dyspnoea and elevated NT-proBNP irrespective of the presumptive cause of dyspnoea, of whom 10% had HFmrEF and 41% HFpEF. However, significant non-cardiac diagnoses related to 9 out of 10 with HFpEF with pulmonary disease as the predominant adjudicated problem.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2018-000928","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:17:27Z","timestamp":1561097847000},"page":"e000928","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-9431","authenticated-orcid":false,"given":"Olav Wendelboe","family":"Nielsen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Valeur","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Sajadieh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Fabricius-Bjerre","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Malchau","family":"Carlsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Kober","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"2025081612171948000_6.1.e000928.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.043"},{"key":"2025081612171948000_6.1.e000928.2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.304"},{"key":"2025081612171948000_6.1.e000928.3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025081612171948000_6.1.e000928.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"2025081612171948000_6.1.e000928.5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew082"},{"key":"2025081612171948000_6.1.e000928.6","unstructured":"CM C . Patients Admitted with Heart Failure: Implications of Natriuretic Peptides and Preserved Ejection Fraction : PhD Thesis. University of Copenhagen, 2014."},{"key":"2025081612171948000_6.1.e000928.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi631"},{"key":"2025081612171948000_6.1.e000928.8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-014-9447-6","article-title":"Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence","volume":"19","author":"Hill","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2025081612171948000_6.1.e000928.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.12.014"},{"key":"2025081612171948000_6.1.e000928.10","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jep007"},{"key":"2025081612171948000_6.1.e000928.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm037"},{"key":"2025081612171948000_6.1.e000928.12","first-page":"351","article-title":"Three methods for evaluation of left atrial volume","volume":"9","author":"Jiamsripong","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2025081612171948000_6.1.e000928.13","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90455-A"},{"key":"2025081612171948000_6.1.e000928.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.3.607"},{"key":"2025081612171948000_6.1.e000928.15","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2025081612171948000_6.1.e000928.16","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12635"},{"key":"2025081612171948000_6.1.e000928.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024825"},{"key":"2025081612171948000_6.1.e000928.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.092"},{"key":"2025081612171948000_6.1.e000928.19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.159"},{"key":"2025081612171948000_6.1.e000928.20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.830"},{"key":"2025081612171948000_6.1.e000928.21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of Ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N Engl J Med"},{"key":"2025081612171948000_6.1.e000928.22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ejhf.612","article-title":"Superior performance of N\u2010terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting","volume":"19","author":"Ibrahim","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025081612171948000_6.1.e000928.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808836"},{"key":"2025081612171948000_6.1.e000928.24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cardfail.2016.03.002","article-title":"Targeting comorbidities in elderly patients with heart failure: the OPTIMIZE-HFPEF trial","volume":"22","author":"Mentz","year":"2016","journal-title":"J Card Fail"},{"key":"2025081612171948000_6.1.e000928.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.920298"},{"key":"2025081612171948000_6.1.e000928.26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2016.01.011","article-title":"Optimizing the management of heart failure with preserved ejection fraction in the elderly by targeting comorbidities (OPTIMIZE-HFPEF)","volume":"22","author":"Fu","year":"2016","journal-title":"J Card Fail"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2018-000928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:17:28Z","timestamp":1755371848000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2018-000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,6,20]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/openhrt-2018-000928"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2018-000928","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}